Alzamend Neuro, Inc. 10-Q filing
Filed 2025-09-10 · Report date 2025-07-31 · 2025
Filing metadata
- Accession number
- 0001214659-25-013609
- Form type
- 10-Q
- CIK
- 0001677077
- Primary document
- https://www.sec.gov/Archives/edgar/data/1677077/000121465925013609/u9325010q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Alzamend Neuro, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.7M | - | - |
| Net Income | $-2.7M | - | - |
| Eps Basic | -1.28 | - | - |
| Eps Diluted | -1.28 | - | - |
| Cash And Equivalents | $5.6M | - | - |
| Total Assets | $6.3M | - | - |
| Total Liabilities | $983,311 | - | - |
| Shareholders Equity | $5.3M | - | - |
| Operating Cash Flow | $-2.4M | - | - |